Aclaris Therapeutics Inc (ACRS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ACRS quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Aclaris Therapeutics Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent19.96
Available-for-sale Securities, Debt Securities, Current MA70.79
Cash & Short-term Investments89.00
Accounts receivable0.00
Other Current Assets5.57
Prepaid Expense And Other Assets Current0.00
Total Current Assets96.32
Equipment/Property/Plant Net0.76
Intangible Assets0.00
Long-term investments60.61
Other Assets, Noncurrent63.38
Total Assets160.46
Liabilities
Accounts Payable, Current AC13.16
Accrued Liabilities, Current AC8.79
Other Liabilities, Current6.70
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities28.65
Total Long-term Debt0.00
Other liabilities, Noncurrent28.73
Operating Lease Liability Current-
Deferred Income Tax Liabilities Net-
Total Liabilities57.38
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,070.26
Retained Earnings / Accumulated Deficit-967.78
Other Equity0.61
Common Stockholder's Equity103.08
Total Stockholder's Equity103.08
Liabilities & Stockholder's Equity160.46
4 historic quarters locked

Sign in to unlock the full Aclaris Therapeutics Inc balance sheet history.

About Aclaris Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-020540

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License